1 option
investigating the food and drug administration decisions on novel drugs : transparency and disclosure.
- Format:
- Video
- Language:
- English
- Subjects (All):
- United States. Food and Drug Administration.
- United States.
- Medicine--United States--History.
- Medicine.
- Medicine--United States--Political aspects.
- Transparency (Ethics) in government--United States.
- Transparency (Ethics) in government.
- Physical Description:
- 1 online resource (1 video file (00:23:31)) : sound, colour
- Place of Publication:
- London : Sage Publications, Ltd., 2026.
- Language Note:
- Closed-captioned in English.
- Summary:
- Robert Kaplan, PhD, senior scholar, Stanford University, discusses investigating transparency and disclosure in food and drug administration (FDA) decisions on novel drugs, including historical and political context, steps taken to examine a particular drug and associated trials, the importance of greater transparency, the impacts of greater transparency on findings, and the statistical, real-world, and policy implications of the research findings.
- Participant:
- Academic, Robert Kaplan PhD.
- Notes:
- Description based on XML content.
- ISBN:
- 1-03-624628-0
- 9781036246280
- OCLC:
- 1565874437
- Publisher Number:
- 301536
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.